Your browser doesn't support javascript.
loading
Correction to: Functional impairment and disability among patients with migraine: evaluation of galcanezumab in a long-term, open-label study.
Ford, Janet H; Stauffer, Virginia L; McAllister, Peter; Akkala, Sreelatha; Sexson, Matthew; Ayer, David W; Wang, Shufang.
Afiliação
  • Ford JH; Eli Lilly and Company, 893 S. Delaware Street, Indianapolis, IN, 46225, USA. ford_janet@lilly.com.
  • Stauffer VL; Eli Lilly and Company, 893 S. Delaware Street, Indianapolis, IN, 46225, USA.
  • McAllister P; New England Institute for Neurology and Headache, Stamford, USA.
  • Akkala S; Eli Lilly Services India Pvt Ltd, Bengaluru, India.
  • Sexson M; Eli Lilly and Company, 893 S. Delaware Street, Indianapolis, IN, 46225, USA.
  • Ayer DW; Eli Lilly and Company, 893 S. Delaware Street, Indianapolis, IN, 46225, USA.
  • Wang S; Eli Lilly and Company, 893 S. Delaware Street, Indianapolis, IN, 46225, USA.
Qual Life Res ; 30(2): 465-466, 2021 Feb.
Article em En | MEDLINE | ID: mdl-33340061
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article